1 month Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives Consensus Rating of “Moderate Buy” from AnalystsMarketBeat
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) has been given an average rating of “Moderate Buy” by the five ratings firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a…
Nasdaq 100 · Pharmaceuticals · Science
X